Summary:
By Express News ServiceHYDERABAD: A Hyderabad-based company applied for a patent and clinical trial approval for a first-of-its-kind immunoglobulin Covid-19 injection — a treatment method similar to plasma therapy. Speaking to Express, Dr Sreehari Y, chairman of MRPA Corporation, said, “We started work on the research three months ago when the first Covid-19 case was reported in China. Different procedures may be used to filter immunoglobulins from the blood”.Is the procedure similar to the much-talked-about plasma therapy? “The concept is similar, but in plasma therapy if one gives a dose of 200ml plasma, there is no way of adjusting it. But ,with Human Covid-19 Injection, the dosage of immunoglobulins can be adjusted as per the severity of the case,” Dr Sreehari said..